vs
Essex Property Trust（ESS）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Essex Property Trust的季度营收约是Penumbra Inc的1.2倍（$479.6M vs $385.4M），Essex Property Trust净利率更高（17.9% vs 12.3%，领先5.6%），Penumbra Inc同比增速更快（22.1% vs 5.5%），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 6.0%）
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
ESS vs PEN — 直观对比
营收规模更大
ESS
是对方的1.2倍
$385.4M
营收增速更快
PEN
高出16.6%
5.5%
净利率更高
ESS
高出5.6%
12.3%
两年增速更快
PEN
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $479.6M | $385.4M |
| 净利润 | $85.7M | $47.3M |
| 毛利率 | 70.0% | 68.0% |
| 营业利润率 | 31.7% | 15.4% |
| 净利率 | 17.9% | 12.3% |
| 营收同比 | 5.5% | 22.1% |
| 净利润同比 | -71.6% | 40.6% |
| 每股收益（稀释后） | $1.24 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESSPEN
| Q4 25 | $479.6M | $385.4M | ||
| Q3 25 | $473.3M | $354.7M | ||
| Q2 25 | $469.8M | $339.5M | ||
| Q1 25 | $464.6M | $324.1M | ||
| Q4 24 | $454.5M | $315.5M | ||
| Q3 24 | $450.7M | $301.0M | ||
| Q2 24 | $442.4M | $299.4M | ||
| Q1 24 | $426.9M | $278.7M |
净利润ESSPEN
| Q4 25 | $85.7M | $47.3M | ||
| Q3 25 | $172.7M | $45.9M | ||
| Q2 25 | $231.5M | $45.3M | ||
| Q1 25 | $212.8M | $39.2M | ||
| Q4 24 | $301.7M | $33.7M | ||
| Q3 24 | $125.5M | $29.5M | ||
| Q2 24 | $99.0M | $-60.2M | ||
| Q1 24 | $285.1M | $11.0M |
毛利率ESSPEN
| Q4 25 | 70.0% | 68.0% | ||
| Q3 25 | 69.2% | 67.8% | ||
| Q2 25 | 70.7% | 66.0% | ||
| Q1 25 | 69.6% | 66.6% | ||
| Q4 24 | 70.0% | 66.8% | ||
| Q3 24 | 69.5% | 66.5% | ||
| Q2 24 | 70.8% | 54.4% | ||
| Q1 24 | 69.7% | 65.0% |
营业利润率ESSPEN
| Q4 25 | 31.7% | 15.4% | ||
| Q3 25 | 44.5% | 13.8% | ||
| Q2 25 | 59.5% | 12.0% | ||
| Q1 25 | 55.3% | 12.4% | ||
| Q4 24 | 67.0% | 13.6% | ||
| Q3 24 | 28.6% | 11.7% | ||
| Q2 24 | 31.1% | -27.0% | ||
| Q1 24 | 31.0% | 4.3% |
净利率ESSPEN
| Q4 25 | 17.9% | 12.3% | ||
| Q3 25 | 36.5% | 12.9% | ||
| Q2 25 | 49.3% | 13.3% | ||
| Q1 25 | 45.8% | 12.1% | ||
| Q4 24 | 66.4% | 10.7% | ||
| Q3 24 | 27.8% | 9.8% | ||
| Q2 24 | 22.4% | -20.1% | ||
| Q1 24 | 66.8% | 3.9% |
每股收益（稀释后）ESSPEN
| Q4 25 | $1.24 | $1.20 | ||
| Q3 25 | $2.56 | $1.17 | ||
| Q2 25 | $3.44 | $1.15 | ||
| Q1 25 | $3.16 | $1.00 | ||
| Q4 24 | $4.00 | $0.88 | ||
| Q3 24 | $1.84 | $0.75 | ||
| Q2 24 | $1.45 | $-1.55 | ||
| Q1 24 | $4.25 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $76.2M | $186.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.5B | $1.4B |
| 总资产 | $13.2B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESSPEN
| Q4 25 | $76.2M | $186.9M | ||
| Q3 25 | $66.0M | $321.0M | ||
| Q2 25 | $58.7M | $421.8M | ||
| Q1 25 | $98.7M | $376.1M | ||
| Q4 24 | $66.8M | $324.4M | ||
| Q3 24 | $71.3M | $280.5M | ||
| Q2 24 | $55.2M | $288.3M | ||
| Q1 24 | $499.0M | $223.1M |
总债务ESSPEN
| Q4 25 | — | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.4B | — | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | — | ||
| Q1 24 | $6.6B | — |
股东权益ESSPEN
| Q4 25 | $5.5B | $1.4B | ||
| Q3 25 | $5.6B | $1.4B | ||
| Q2 25 | $5.6B | $1.3B | ||
| Q1 25 | $5.6B | $1.2B | ||
| Q4 24 | $5.5B | $1.2B | ||
| Q3 24 | $5.4B | $1.1B | ||
| Q2 24 | $5.5B | $1.2B | ||
| Q1 24 | $5.5B | $1.2B |
总资产ESSPEN
| Q4 25 | $13.2B | $1.8B | ||
| Q3 25 | $13.2B | $1.7B | ||
| Q2 25 | $13.2B | $1.7B | ||
| Q1 25 | $13.2B | $1.6B | ||
| Q4 24 | $12.9B | $1.5B | ||
| Q3 24 | $12.6B | $1.5B | ||
| Q2 24 | $12.5B | $1.5B | ||
| Q1 24 | $12.9B | $1.6B |
负债/权益比ESSPEN
| Q4 25 | — | — | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 1.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1B | $86.5M |
| 自由现金流经营现金流 - 资本支出 | — | $68.0M |
| 自由现金流率自由现金流/营收 | — | 17.7% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | 12.53× | 1.83× |
| 过去12个月自由现金流最近4个季度 | — | $174.9M |
8季度趋势，按日历期对齐
经营现金流ESSPEN
| Q4 25 | $1.1B | $86.5M | ||
| Q3 25 | $342.6M | $58.3M | ||
| Q2 25 | $216.1M | $44.9M | ||
| Q1 25 | $281.5M | $49.0M | ||
| Q4 24 | $1.1B | $51.1M | ||
| Q3 24 | $316.2M | $56.5M | ||
| Q2 24 | $218.9M | $22.6M | ||
| Q1 24 | $314.9M | $38.3M |
自由现金流ESSPEN
| Q4 25 | — | $68.0M | ||
| Q3 25 | — | $42.0M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.5M | ||
| Q4 24 | — | $45.7M | ||
| Q3 24 | — | $51.0M | ||
| Q2 24 | — | $18.1M | ||
| Q1 24 | — | $32.5M |
自由现金流率ESSPEN
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | 11.8% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | — | 16.9% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 11.7% |
资本支出强度ESSPEN
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 2.1% |
现金转化率ESSPEN
| Q4 25 | 12.53× | 1.83× | ||
| Q3 25 | 1.98× | 1.27× | ||
| Q2 25 | 0.93× | 0.99× | ||
| Q1 25 | 1.32× | 1.25× | ||
| Q4 24 | 3.54× | 1.52× | ||
| Q3 24 | 2.52× | 1.91× | ||
| Q2 24 | 2.21× | — | ||
| Q1 24 | 1.10× | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESS
暂无分部数据
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
